Lafutidine

DB12770InvestigationalSmall molecule

Lafutidine has been investigated in Peptic Ulcer, Community-acquired Pneumonia, and Gastroesophageal Reflux Disease (GERD).

Mechanism: Pharmacologically active on Histamine H2 receptor
Curator reviewed
Formula / weight: C₂₂H₂₉N₃O₄S · 431.55 g/mol (avg)
Code names: FRG-8813

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyKMZQAVXSMUKBPD-DJWKRKHSSA-NSMILESO=C(CS(=O)CC1=CC=CO1)NC\C=C/COC1=NC=CC(CN2CCCCC2)=C1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

124Drug interactionsStructured to mechanism, not free text

7Clinical trialsPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 13 drug categories

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Lafutidine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.